Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models

Parwiz Abrahimi, Jonathan F. Khan, Alyssa Duren-Lubanski, Winson Cai, Yacine Marouf, Nan Chen, Daniel Hirschhorn, Renata Mammone, Ileana C. Miranda, Jacob E. Tallman, Alejandra Vela-Moreno, Mohamad Hamieh, Bishoy M. Faltas, Thomas M. Carroll, Micaela L. Everitt, Hari K.K. Subramanian, Hikmat A. Al-Ahmadie, Olivier Elemento, Benjamin D. Hopkins, Douglas S. Scherr, Renier J. Brentjens, Jedd D. Wolchok, Taha Merghoub

Open source

DOI: 10.1084/jem.20250699
Published: 2026-06-26
Container: Journal of Experimental Medicine
Publisher: Rockefeller University Press
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1084/jem.20250699,
  title = {Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models},
  author = {Parwiz Abrahimi and Jonathan F. Khan and Alyssa Duren-Lubanski and Winson Cai and Yacine Marouf and Nan Chen and Daniel Hirschhorn and Renata Mammone and Ileana C. Miranda and Jacob E. Tallman and Alejandra Vela-Moreno and Mohamad Hamieh and Bishoy M. Faltas and Thomas M. Carroll and Micaela L. Everitt and Hari K.K. Subramanian and Hikmat A. Al-Ahmadie and Olivier Elemento and Benjamin D. Hopkins and Douglas S. Scherr and Renier J. Brentjens and Jedd D. Wolchok and Taha Merghoub},
  year = {2026},
  journal = {Journal of Experimental Medicine},
  doi = {10.1084/jem.20250699},
  url = {https://doi.org/10.1084/jem.20250699}
}

RIS

TY  - JOUR
TI  - Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models
AU  - Parwiz Abrahimi
AU  - Jonathan F. Khan
AU  - Alyssa Duren-Lubanski
AU  - Winson Cai
AU  - Yacine Marouf
AU  - Nan Chen
AU  - Daniel Hirschhorn
AU  - Renata Mammone
AU  - Ileana C. Miranda
AU  - Jacob E. Tallman
AU  - Alejandra Vela-Moreno
AU  - Mohamad Hamieh
AU  - Bishoy M. Faltas
AU  - Thomas M. Carroll
AU  - Micaela L. Everitt
AU  - Hari K.K. Subramanian
AU  - Hikmat A. Al-Ahmadie
AU  - Olivier Elemento
AU  - Benjamin D. Hopkins
AU  - Douglas S. Scherr
AU  - Renier J. Brentjens
AU  - Jedd D. Wolchok
AU  - Taha Merghoub
PY  - 2026
JO  - Journal of Experimental Medicine
DO  - 10.1084/jem.20250699
UR  - https://doi.org/10.1084/jem.20250699
ER  -

APA

Abrahimi, P., Khan, J. F., Duren-Lubanski, A., Cai, W., Marouf, Y., Chen, N., Hirschhorn, D., Mammone, R., Miranda, I. C., Tallman, J. E., Vela-Moreno, A., Hamieh, M., Faltas, B. M., Carroll, T. M., Everitt, M. L., Subramanian, H. K., Al-Ahmadie, H. A., Elemento, O., Hopkins, B. D., Scherr, D. S., Brentjens, R. J., Wolchok, J. D., & Merghoub, T. (2026). Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20250699

Source records

crossref · retrieved 2026-09-26T00:13:03.238Z